Communication between patients, peers, and care providers through a mobile health intervention supporting medication-assisted treatment for opioid use disorder.

The study was a small pilot with 25 patients and 3 providers, so it cannot show whether the app works in larger groups. It analysed message content and usage only. It did not compare the app with usual care or test clinical outcomes such as retention, medication adherence, or relapse. Community message board use was low, with 9 members in the first month and 1 in the sixth month, so peer support findings may not generalise. Participants were referred as high risk for disengagement, and none who were offered enrollment declined, which may limit how the sample compares with other clinics. The study did not include follow-up interviews about app feedback, perceived usefulness, or barriers to continued use. The COVID-19 pandemic disrupted clinic care during the pilot, and messaging use increased, so patterns may be hard to generalise as clinics return to pre-pandemic care. Members without smartphones were given phones and subsidized data, so lack of a smartphone was not a barrier in this sample. Participants who agreed to use a novel app may have been more comfortable with technology than patients who would not enroll.

Do not read the reported increase in messaging during the pandemic as proof that the app improved opioid use disorder treatment. The study was a small pilot that analysed message content only. It did not compare the app with usual care or test retention, medication adherence, or relapse.